Related Experiment Video
Updated: Aug 17, 2025
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.9K
Renal Thrombotic Microangiopathy: A Review
Dominique Suzanne Genest1, Christopher J Patriquin2, Christoph Licht3
1Division of Nephrology, University Health Network, Toronto, Ontario, Canada; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
Summary
Thrombotic microangiopathy (TMA) involves kidney damage and can be hard to diagnose. Early treatment is crucial for better outcomes in patients with this condition.
Area of Science:
- Nephrology
- Hematology
- Pathology
Background:
- Thrombotic microangiopathy (TMA) is characterized by endothelial injury, leading to microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
- Renal-limited TMA presents diagnostic challenges, potentially delaying critical interventions.
- Advances in understanding TMA pathophysiology have led to new diagnostic tools and therapies for conditions like thrombotic thrombocytopenic purpura and complement-mediated TMA.
Purpose of the Study:
- To review the clinical and pathological features of kidney-involved TMA.
- To discuss disease-specific mechanisms underlying endothelial injury in TMA.
- To outline diagnostic approaches and treatment strategies, including emerging therapies.
Main Methods:
- Review of clinical presentations and pathological hallmarks of renal TMA.
- Analysis of disease-specific mechanisms contributing to endothelial injury.
- Discussion of diagnostic criteria and therapeutic interventions.
Main Results:
- Renal-limited TMA can be challenging to diagnose, impacting timely treatment initiation.
- Understanding TMA pathophysiology is key to developing targeted therapies.
- Novel diagnostic tools and life-saving treatments are available for specific TMA entities.
Conclusions:
- Prompt diagnosis and empirical treatment of TMA are essential to reduce morbidity and mortality.
- This review covers diagnostic strategies and therapeutic options for TMA affecting the kidney.
- Emerging targeted therapies hold promise for managing TMA.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
16
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
01:30Venous Thrombosis I: Introduction
23
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
23
01:30Venous Thrombosis IV: Nursing Management
19
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
827
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
827
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
24
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
24
01:16Clot Retraction and Fibrinolysis
6.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.6K